BioCardia, Inc. (BCDA) — Institutional Holders, Q2 2026

21 institutional investment managers reported a BCDA position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.6M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

BCDA in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

6

Added to

4

Trimmed

3

Sold out

5

Biggest buyers

  1. CITIGROUPNew · +397,594 sh+$493.0K
  2. CM ManagementAdded · +170,000 sh+$210.8K
  3. Pingora PartnersAdded · +84,643 sh+$105.0K
  4. UBS Group AGNew · +77,619 sh+$96.2K
  5. StoneX GroupNew · +20,020 sh+$24.8K

Biggest sellers

  1. CITADEL ADVISORSTrimmed · -40,428 sh-$50.1K
  2. GEODE CAPITAL MANAGEMENTTrimmed · -27,623 sh-$34.3K
  3. XTX Topco LtdSold out · -24,270 sh-$30.1K
  4. Virtu FinancialSold out · -20,355 sh-$25.2K
  5. TWO SIGMA SECURITIESSold out · -14,780 sh-$18.3K

BCDA 13F holders ranked 1–21 of 21

Institutional investors reporting a position in BioCardia, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
CITIGROUP#1 · 397,594 sh$493.0KNew
CM Management#2 · 300,000 sh$372.0K+130.8%
VANGUARD CAPITAL MANAGEMENT#3 · 124,591 sh$154.5K0.0%
Pingora Partners#4 · 120,382 sh$149.3K+236.8%
UBS Group AG#5 · 77,619 sh$96.2KNew
GEODE CAPITAL MANAGEMENT#6 · 66,664 sh$82.7K-29.3%
VANGUARD FIDUCIARY#7 · 66,270 sh$82.2K0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP#8 · 38,809 sh$48.1K0.0%
BROWN ADVISORY#9 · 35,538 sh$44.1K0.0%
COMMONWEALTH EQUITY SERVICES#10 · 23,383 sh$29.0K+27.9%
CITADEL ADVISORS#11 · 22,956 sh$28.5K-63.8%
StoneX Group#12 · 20,020 sh$24.8KNew
WEALTH ENHANCEMENT ADVISORY SERVICES#13 · 18,500 sh$16.9KNew
GSA CAPITAL PARTNERS LLP#14 · 12,862 sh$16.0KNew
Tower Research Capital (TRC)#15 · 3,187 sh$4.0K+7.0%
MORGAN STANLEY#16 · 3,105 sh$3.9K0.0%
Allied Private Wealth#17 · 1,449 sh$1.4K—
Global Retirement Partners#18 · 411 sh$510.00—
SBI Securities , Ltd.#19 · 9 sh$11.000.0%
OSAIC#20 · 1 sh$1.000.0%
Caitong International Asset Management , Ltd#21 · 1 sh$1.00New

Funds that sold out of BCDA in Q2 2026 (5)

Held BCDA at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held BCDA in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
XTX Topco Ltd24,270 sh$29.4K
Virtu Financial20,355 sh$25.0K
TWO SIGMA SECURITIES14,780 sh$17.9K
RENAISSANCE TECHNOLOGIES13,900 sh$16.8K
Vanguard Global Advisers268 sh$324.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.